Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance

被引：0
|
作者：
Yee Soo Kim
Simerjeet Brar
Natalie D’Albo
Amit Dey
Sachin Shah
Sarju Ganatra
Sourbha S. Dani
机构：
[1] Lahey Hospital and Medical Center,Department of Internal Medicine
[2] Georgetown University Medical Center,Department of Internal Medicine
[3] Lahey Hospital and Medical Center,Beth Israel Lahey Health, Department of Cardiovascular Medicine
来源：
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词：
Sacubitril/valsartan; FDA Adverse Event Reporting System; Real-world pharmacovigilance; Disproportionality analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：915 / 924
页数：9
相关论文
共 50 条
  • [31] Sacubitril/Valsartan efficacy on functional, laboratory, echocardiographic parameters: a real-world study
    Fioretti, F.
    Piazzani, M.
    Cani, D. S.
    Madureri, A.
    Nodari, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 138 - 138
  • [32] Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany
    Wachter, Rolf
    Fonseca, Ana F.
    Balas, Bogdan
    Kap, Elisabeth
    Engelhard, Johanna
    Schlienger, Raymond
    Klebs, Sven
    Wirta, Sara Bruce
    Kostev, Karel
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (05) : 588 - 597
  • [33] Effects of sacubitril/valsartan on functional status and exercise capacity in real-world patients
    Lau, Chirik Wah
    Martens, Pieter
    Lambeets, Seppe
    Dupont, Matthias
    Mullens, Wilfried
    ACTA CARDIOLOGICA, 2019, 74 (05) : 405 - 412
  • [34] Effectiveness and safety of sacubitril/valsartan for patients with hypertension and heart failure in the real-world setting: A retrospective study in China
    Zuo, Chengchun
    Li, Xiaoye
    Fan, Linlin
    Li, Jing
    Tian, Dan
    Chen, Can
    Li, Xiaoyu
    Lv, Qianzhou
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (10) : 1539 - 1547
  • [35] Sacubitril/valsartan efficacy on functional, laboratory, echocardiographic parameters: a real-world study
    Lupi, Laura
    Castlello, Assunta
    Papa, Maria
    Bonelli, Andrea
    Piazzani, Mariangela
    Arrigoni, Luca
    Tomasoni, Daniela
    Fioretti, Francesco
    Gheza, Miriam
    Metra, Marco
    Nodari, Savina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J137 - J137
  • [36] Sacubitril-valsartan in the real world: From theory to clinical practice
    Fontes-Carvalho, Ricardo
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (06) : 497 - 498
  • [37] The history and mystery of sacubitril/valsartan: From clinical trial to the real world
    Zhang, Mingsong
    Zou, Yifei
    Li, Yangxue
    Wang, He
    Sun, Wei
    Liu, Bin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [38] Efficacy and safety of sacubitril-valsartan in heart failure: a meta-analysis of randomized controlled trials
    Zhang, Hongzhou
    Huang, Tieqiu
    Shen, Wen
    Xu, Xiuxiu
    Yang, Pingping
    Zhu, Dan
    Fang, Haiyang
    Wan, Hongbing
    Wu, Tao
    Wu, Yanqing
    Wu, Qinghua
    ESC HEART FAILURE, 2020, 7 (06): : 3841 - 3850
  • [39] IMPACT OF SACUBITRIL/VALSARTAN ON CLINICAL OUTCOMES IN HEART FAILURE USING REAL-WORLD DATA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rahhal, Alaa
    Kasem, Mohamed
    Orabi, Bassant
    Abuyousef, Safae
    Hamou, Fatima
    Mahfouz, Ahmed
    Alyafei, Sumaya
    Hassan, Emad Ahmed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 420 - 420
  • [40] Cost-effectiveness of Sacubitril/Valsartan in acute and chronic heart failure with reduced ejection fraction: From randomized controlled trials to real-world evidence
    Lin, Y. M.
    Yang, C. T.
    Kuo, F. S.
    Toh, H. S.
    Yang, I. N.
    Hung, C. Y.
    Liao, C. T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 305 - 305
12345